上亞科技股份有限公司 Approved
最後更新時間 2025/07/18 , 07:14 AM
最後更新時間 2025/07/18 , 07:14 AM
負責人
Huang,Kun-Jian
統一編號
84659035
成立日期
1994/01/07
資本額
NT$1,500,000,000
實收資本額
NT$443,000,000
股票代號
6130
電話
#16
地址
9-12F, No. 188, Sec. 5, Nanjing E. Rd., Songshan Dist., Taipei City, 105, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Huang,Kun-Jian Chairman 0.30%
Huang,Qian-Kui Director 18.06% XING BAO ELECTRONIC TECHNOLOGY CO., LTD.
Su,Yu-Cheng Director 18.06% XING BAO ELECTRONIC TECHNOLOGY CO., LTD.
Dai,Cheng-Yi Director 15.35% HE ZHONG INVESTMENT CO., LTD.
Ke,Cui-Ting Independent Director 0.00%
Wu,Huang-Qing Independent Director 0.00%
Lin,Yi-Bin Independent Director 0.00%
營業項目
  • Wholesale of Pharmaceutical and Medical Goods(457111)
  • Wholesale of Pharmaceutical and Medical Goods(457112)
  • 公司歷程
  • Change Company Name to SHANGYA TECHNOLOGY CO.,LTD.
    2023/07/05
  • Change Company Name to XINGBAO INTERNATIONAL CO., LTD. (FORMER NAME: GENE INTERNATIONAL BIOMEDICAL CO., LTD.)
    2022/06/30
  • Change Company Name to SINGBAO INTERNATIONAL CO., LTD.
    2022/05/13
  • Change Company Name to SINGBAO INTERNATIONAL CO., LTD.
    2022/01/22
  • Change Company Name to XINGBAO INTERNATIONAL CO., LTD. (FORMER NAME: GENE INTERNATIONAL BIOMEDICAL CO., LTD.)
    2022/01/22
  • Change Company Name to SINGBAO INTERNATIONAL CO., LTD.
    2021/11/30
  • Change Company Name to XINGBAO INTERNATIONAL CO., LTD. (FORMER NAME: GENE INTERNATIONAL BIOMEDICAL CO., LTD.)
    2021/11/30
  • Change Company Name to XINGBAO INTERNATIONAL CO., LTD. (FORMER NAME: GENE INTERNATIONAL BIOMEDICAL CO., LTD.)
    2021/10/06
  • Change Company Name to SINGBAO INTERNATIONAL CO., LTD.
    2020/11/06
  • Change Company Name to SINGBAO INTERNATIONAL CO., LTD.
    2020/07/28
  • Change Company Name to XINGBAO INTERNATIONAL CO., LTD. (FORMER NAME: GENE INTERNATIONAL BIOMEDICAL CO., LTD.)
    2020/07/28
  • Change Company Name to XINGBAO INTERNATIONAL CO., LTD. (FORMER NAME: GENE INTERNATIONAL BIOMEDICAL CO., LTD.)
    2020/07/01
  • Change Company Name to XINGBAO INTERNATIONAL CO., LTD. (FORMER NAME: GENE INTERNATIONAL BIOMEDICAL CO., LTD.)
    2020/02/10
  • Change Company Name to SINGBAO INTERNATIONAL CO., LTD.
    2020/02/10
  • Change Company Name to XINGBAO INTERNATIONAL CO., LTD. (FORMER NAME: GENE INTERNATIONAL BIOMEDICAL CO., LTD.)
    2019/11/01
  • Change Company Name to SINGBAO INTERNATIONAL CO., LTD.
    2019/11/01
  • Change Company Name to XINGBAO INTERNATIONAL CO., LTD. (FORMER NAME: GENE INTERNATIONAL BIOMEDICAL CO., LTD.)
    2019/08/06
  • Change Company Name to SINGBAO INTERNATIONAL CO., LTD.
    2019/08/06
  • Change Company Name to XINGBAO INTERNATIONAL CO., LTD. (FORMER NAME: GENE INTERNATIONAL BIOMEDICAL CO., LTD.)
    2019/05/30
  • Change Company Name to SINGBAO INTERNATIONAL CO., LTD.
    2019/05/30
  • Change Company Name to SINGBAO INTERNATIONAL CO., LTD.
    2018/10/08
  • Change Company Name to XINGBAO INTERNATIONAL CO., LTD. (FORMER NAME: GENE INTERNATIONAL BIOMEDICAL CO., LTD.)
    2018/05/18
  • Change Company Name to SINGBAO INTERNATIONAL CO., LTD.
    2018/04/11
  • Change Company Name to SINGBAO INTERNATIONAL CO., LTD.
    2017/03/14
  • Change Company Name to XINGBAO INTERNATIONAL CO., LTD. (FORMER NAME: GENE INTERNATIONAL BIOMEDICAL CO., LTD.)
    2017/03/14
  • Change Person in Charge to Huang,Kun-Jian
    2017/03/14
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD. (FORMER NAME: DAYU CO., LTD.)
    2017/02/08
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD.
    2017/02/08
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD.
    2016/08/09
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD. (FORMER NAME: DAYU CO., LTD.)
    2016/06/04
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD.
    2016/03/07
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD. (FORMER NAME: DAYU CO., LTD.)
    2015/07/13
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD. (FORMER NAME: DAYU CO., LTD.)
    2015/02/03
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD.
    2015/02/03
  • Change Person in Charge to Ceng,You-Quan
    2015/02/03
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD. (FORMER NAME: DAYU CO., LTD.)
    2014/08/11
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD.
    2014/08/11
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD.
    2014/07/11
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD.
    2013/11/14
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD. (FORMER NAME: DAYU CO., LTD.)
    2013/11/14
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD.
    2013/07/03
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD. (FORMER NAME: DAYU CO., LTD.)
    2013/07/03
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD. (FORMER NAME: DAYU CO., LTD.)
    2012/09/10
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD.
    2012/07/12
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD. (FORMER NAME: DAYU CO., LTD.)
    2011/07/15
  • Change Company Name to GENE INTERNATIONAL BIOMEDICAL CO., LTD.
    2011/01/07
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 39,691 195,354 231,117
    Operating cost 26,795 126,150 154,928
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 12,896 69,204 76,189
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 12,896 69,204 76,189
    Operating expenses 29,432 104,658 83,932
    Other gain (loss), net - - -
    Operating profit (loss) -16,536 -35,454 -7,743
    Non-operating income and expenses -3,457 4,558 -102,225
    Net profit (loss) before tax -19,993 -30,896 -109,968
    Income tax expense (benefits) -1,336 2,364 1,409
    Net profit (loss) of ongoing business for the current period -18,657 -33,260 -111,377
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -18,657 -33,260 -111,377
    Other comprehensive profit (loss), net 3,409 -3,563 -3,326
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -15,248 -36,823 -114,703
    Net profit (loss) attributable to owners of parent company -16,697 -33,428 -80,043
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests -1,960 168 -31,334
    Comprehensive profit (loss) attributable to owners of parent company -14,447 -36,551 -83,369
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests -801 -272 -31,334
    Basic earnings per share (yuan) 0 0 -1
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities -11,954 11,282 57
    Net cash inflows (outflows) from investing activities -42,021 19,887 -104,519
    Net cash inflow (outflow) from financing activities 27,553 -36,367 -16,341
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - - -
    Increase (decrease) in cash and cash equivalents in the current period -26,422 -5,198 -120,803
    Beginning balance of cash and cash equivalents 241,555 246,753 367,556
    Ending balance of cash and cash equivalents 215,133 241,555 246,753
    項目 2025 2024 2023
    Current asset 296,001 325,327 347,141
    Non-current asset 651,788 653,082 619,763
    Total asset 947,789 978,409 966,904
    Current liability 104,448 146,376 71,040
    Non-current liability 112,051 85,798 95,430
    Total liability 216,499 232,174 166,470
    share capital 443,000 443,000 443,000
    Equity - secruity token - - -
    capital reserve 230,511 230,208 337,704
    retained earning -50,125 -33,428 -86,048
    Other equity -12,587 -14,837 -11,714
    Treasury stock - - -
    Total equity attributable to owners of parent company 610,799 624,943 682,942
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 120,491 121,292 117,492
    Total Equity 731,290 746,235 800,434
    Share capital awaiting retirement (unit: share) - - -
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 13 14 15
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
    專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Compensation for damage
    2024
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。